10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q3 2018

Filing Information

Form Type	10-Q
Accession Number	`0001213900-18-006121`
Period End Date	20180331
Filing Date	20180514
Fiscal Year	2018
Fiscal Period	Q3
XBRL Instance	rlmd-20180331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 44 Cash Flow Statement 62

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Promissory notes payable, net of discount	`DebtInstrumentUnamortizedDiscountNoncurrent`	-	USD	Point-in-time
Promissory notes payable, net of discount	`DebtInstrumentUnamortizedDiscountNoncurrent`	$5.63M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.76M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.26M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$232.60K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Lease payments receivable - short term	`LeaseIncentiveReceivableCurrent`	$63.15K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Lease payments receivable - short term	`LeaseIncentiveReceivableCurrent`	$59.32K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$472.49K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$160.28K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.48M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.47M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.55M	shares	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$2.31K	USD	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$3.21K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.53M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$21.96K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.55M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$21.60K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.53M	shares	Point-in-time
Lease payments receivable - long term	`LeaseIncentiveReceivableNoncurrent`	$337.73K	USD	Point-in-time
Lease payments receivable - long term	`LeaseIncentiveReceivableNoncurrent`	$289.87K	USD	Point-in-time
Total assets	`Assets`	$4.80M	USD	Point-in-time
Total assets	`Assets`	$2.84M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.09M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$529.56K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$394.56K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$458.58K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$276.67K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$27.88K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$3.96M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$175.85K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.38M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.54M	USD	Point-in-time
Promissory notes payable, net of discount of $5,628,720 and $0	`LongTermNotesPayable`	-	USD	Point-in-time
Promissory notes payable, net of discount of $5,628,720 and $0	`LongTermNotesPayable`	$1.58M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.11M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.38M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 12,548,870 and 12,528,374 shares issued and outstanding, respectively	`CommonStockValue`	$12.53K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 12,548,870 and 12,528,374 shares issued and outstanding, respectively	`CommonStockValue`	$12.55K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$88.67M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$86.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-90.99M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-85.38M	USD	Point-in-time
Total stockholders' (deficit) equity	`StockholdersEquity`	$-2.32M	USD	Point-in-time
Total stockholders' (deficit) equity	`StockholdersEquity`	$1.46M	USD	Point-in-time
Total liabilities and stockholders' (deficit) equity	`LiabilitiesAndStockholdersEquity`	$4.80M	USD	Point-in-time
Total liabilities and stockholders' (deficit) equity	`LiabilitiesAndStockholdersEquity`	$2.84M	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$1.98M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.67M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.11M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$490.69K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.00M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$4.33M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.79M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$883.01K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$5.44M	USD	3 Qtrs
Total Operating Expenses	`OperatingExpenses`	$2.55M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$2.28M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$4.99M	USD	3 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-5.44M	USD	3 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-2.28M	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-4.99M	USD	3 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-2.55M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$244.07K	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$613.07K	USD	3 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-254.86K	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$80.54K	USD	3 Qtrs
Interest (expense) income, net	`InterestIncomeExpenseNonoperatingNet`	$-397.11K	USD	1 Quarter
Interest (expense) income, net	`InterestIncomeExpenseNonoperatingNet`	$-756.00	USD	3 Qtrs
Interest (expense) income, net	`InterestIncomeExpenseNonoperatingNet`	$473.00	USD	1 Quarter
Interest (expense) income, net	`InterestIncomeExpenseNonoperatingNet`	$-706.46K	USD	3 Qtrs
Other income	`OtherNonoperatingIncome`	-	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$2.35K	USD	3 Qtrs
Other income	`OtherNonoperatingIncome`	$170.73K	USD	3 Qtrs
Other income	`OtherNonoperatingIncome`	$56.91K	USD	1 Quarter
Total other (expense) income	`OtherNonoperatingIncomeExpense`	$-623.57K	USD	3 Qtrs
Total other (expense) income	`OtherNonoperatingIncomeExpense`	$783.04K	USD	3 Qtrs
Total other (expense) income	`OtherNonoperatingIncomeExpense`	$-651.97K	USD	1 Quarter
Total other (expense) income	`OtherNonoperatingIncomeExpense`	$301.46K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.61M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.98M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.65M	USD	3 Qtrs
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.45	USD	3 Qtrs
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.26	USD	1 Quarter
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.16	USD	1 Quarter
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.39	USD	3 Qtrs
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.04M	shares	1 Quarter
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.55M	shares	1 Quarter
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.54M	shares	3 Qtrs
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.04M	shares	3 Qtrs

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-5.61M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.98M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.65M	USD	3 Qtrs
Depreciation expense	`Depreciation`	$67.01K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$1.70K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$365.17K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$412.58K	USD	3 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$-80.54K	USD	3 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$-613.07K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$501.20K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	3 Qtrs
Other receivable	`IncreaseDecreaseInOtherReceivables`	$-232.60K	USD	3 Qtrs
Other receivable	`IncreaseDecreaseInOtherReceivables`	-	USD	3 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasePaymentReceivable`	$-44.02K	USD	3 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasePaymentReceivable`	-	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$-312.57K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$-310.54K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$483.53K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-924.28K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-48.41K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$14.76K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-1.49K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.74M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.45M	USD	3 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$2.59K	USD	3 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$47.49K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.59K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-47.49K	USD	3 Qtrs
Proceeds from promissory notes and warrants, net of fees	`ProceedsFromNotesPayable`	-	USD	3 Qtrs
Proceeds from promissory notes and warrants, net of fees	`ProceedsFromNotesPayable`	$6.53M	USD	3 Qtrs
Principal payments of note payable	`RepaymentsOfNotesPayable`	$248.79K	USD	3 Qtrs
Principal payments of note payable	`RepaymentsOfNotesPayable`	$246.09K	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.29M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-246.09K	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-5.74M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.55M	USD	3 Qtrs
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.76M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.26M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.76M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.26M	USD	Point-in-time
Income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Interest	`InterestPaidNet`	$2.74K	USD	3 Qtrs
Interest	`InterestPaidNet`	$2.65K	USD	3 Qtrs
Warrants issued to promissory note holders	`WarrantsIssuedToPromissoryNoteHolders`	-	USD	3 Qtrs
Warrants issued to promissory note holders	`WarrantsIssuedToPromissoryNoteHolders`	$1.27M	USD	3 Qtrs
Warrants issued to placement agent	`WarrantsIssuedToPlacementAgent`	-	USD	3 Qtrs
Warrants issued to placement agent	`WarrantsIssuedToPlacementAgent`	$200.66K	USD	3 Qtrs
Derivative liabilities associated with issuance of promissory notes	`DerivativeLiabilitiesAssociatedWithIssuanceOfPromissoryNotes`	-	USD	3 Qtrs
Derivative liabilities associated with issuance of promissory notes	`DerivativeLiabilitiesAssociatedWithIssuanceOfPromissoryNotes`	$3.86M	USD	3 Qtrs
Financing fees in accounts payable and accrued expenses	`FinancingFeesInAccountsPayableAndAccruedExpenses`	$127.76K	USD	3 Qtrs
Financing fees in accounts payable and accrued expenses	`FinancingFeesInAccountsPayableAndAccruedExpenses`	-	USD	3 Qtrs
Issuances of common stock resulting from cashless exercise of warrants	`StockIssued1`	-	USD	3 Qtrs
Issuances of common stock resulting from cashless exercise of warrants	`StockIssued1`	$17.00	USD	3 Qtrs
Issuance of vested shares of restricted stock	`IssuanceOfVestedSharesOfRestrictedStock`	$38.00	USD	3 Qtrs
Issuance of vested shares of restricted stock	`IssuanceOfVestedSharesOfRestrictedStock`	-	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.